Blue and Green Light Responsive Caged Glutamate.

BODIPY Caged Glu Glutamate Visible light photo-protecting group photoirradiation

Journal

Journal of photochemistry and photobiology. A, Chemistry
ISSN: 1010-6030
Titre abrégé: J Photochem Photobiol A Chem
Pays: Switzerland
ID NLM: 9883240

Informations de publication

Date de publication:
15 Jan 2024
Historique:
pmc-release: 15 01 2025
medline: 6 11 2023
pubmed: 6 11 2023
entrez: 6 11 2023
Statut: ppublish

Résumé

Glutamate (Glu) is an excitatory neurotransmitter that plays a critical role in memory. Brain mapping activities of such pathways relied heavily on the ability to release Glu with spatiotemporal precision. Several photo-protecting groups (PPGs), referred to as photocages or cages, were designed to accomplish the release of Glu upon irradiation. Previously reported Glu cages responded to UV upon irradiation with single photons, which limited their use in vivo experiments due to cytotoxicity. Other caged designs suffered from lower quantum efficiency (QE) of release necessitating higher concentrations and/or longer photoirradiation times. There have been limited examples of cages that respond to visible light with single photon irradiation. Herein, we report the efficient preparation of 11 caged Glu examples that respond to two visible wavelengths, 467 nm (thiocoumarin based) and 515-540 nm (BODIPY based). The kinetics of photouncaging were studied for all caged designs, and we report all quantum efficiencies, i.e., quantum yields (Φ), that ranged from 0.0001-0.65. Two of the BODIPY cages are reported here for the first time, and one, Me-BODIPY-Br-Glu, shows the most efficient Glu release with a QE of 0.65. Similar caged designs can be extended to the inhibitory neurotransmitter, GABA. This would enable the use of two visible wavelengths to modulate the release of excitatory and inhibitory neurotransmitters upon demand via optical control.

Identifiants

pubmed: 37928883
doi: 10.1016/j.jphotochem.2023.115183
pmc: PMC10621743
mid: NIHMS1936041
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : NIGMS NIH HHS
ID : R15 GM112119
Pays : United States
Organisme : NIH HHS
ID : S10 OD021758
Pays : United States

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Molecules. 2020 Nov 15;25(22):
pubmed: 33203096
Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):13940-5
pubmed: 14615590
Proc Natl Acad Sci U S A. 2003 Feb 4;100(3):1352-7
pubmed: 12540832
Acc Chem Res. 2015 Dec 15;48(12):3064-72
pubmed: 26569596
Nat Neurosci. 2005 Sep;8(9):1263-8
pubmed: 16116447
Chemistry. 2022 Jun 27;28(36):e202200477
pubmed: 35420231
J Inorg Biochem. 2004 Jun;98(6):951-8
pubmed: 15149801
J Am Chem Soc. 2013 Apr 24;135(16):5954-7
pubmed: 23577752
Neuron. 2007 Apr 19;54(2):205-18
pubmed: 17442243
Nat Methods. 2007 Aug;4(8):619-28
pubmed: 17664946
J Neurosci. 2007 Jun 20;27(25):6601-4
pubmed: 17581946
Nat Chem Biol. 2010 Apr;6(4):255-257
pubmed: 20173751
Psychopharmacology (Berl). 1993;111(4):391-401
pubmed: 7870979
Nat Methods. 2010 Feb;7(2):123-5
pubmed: 20037590
Science. 2002 Jun 28;296(5577):2395-8
pubmed: 12089443
J Org Chem. 2019 May 3;84(9):5236-5244
pubmed: 30908906
Molecules. 2022 Jul 31;27(15):
pubmed: 35956851
Eur J Neurosci. 2015 Jan;41(1):5-16
pubmed: 25471355
J Neurosci. 2006 Oct 11;26(41):10380-6
pubmed: 17035522
Sci Rep. 2017 Aug 4;7(1):7349
pubmed: 28779161
Front Synaptic Neurosci. 2019 Jan 09;10:48
pubmed: 30687075
Neuron. 2011 Jul 14;71(1):9-34
pubmed: 21745635
Neuron. 2002 Jan 3;33(1):15-22
pubmed: 11779476
Curr Opin Neurobiol. 2004 Jun;14(3):395-402
pubmed: 15194122
Annu Rev Cell Dev Biol. 2011;27:731-58
pubmed: 21819234
Annu Rev Biochem. 2017 Jun 20;86:845-872
pubmed: 28301742
Chem Rev. 2008 May;108(5):1588-602
pubmed: 18447399
J Physiol. 1993 Jun;465:1-8
pubmed: 7901400
Chembiochem. 2016 May 17;17(10):953-61
pubmed: 26929152
Proc Natl Acad Sci U S A. 1999 Feb 16;96(4):1193-200
pubmed: 9990000
Proc Natl Acad Sci U S A. 2010 Jun 29;107(26):11981-6
pubmed: 20543137
Cell. 2005 Apr 8;121(1):141-52
pubmed: 15820685
Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8689-94
pubmed: 12060707
Eur J Neurosci. 2010 Jun;31(12):2279-91
pubmed: 20529127
J Am Chem Soc. 2020 Sep 2;142(35):15164-15171
pubmed: 32786783
ACS Chem Neurosci. 2018 Nov 21;9(11):2713-2721
pubmed: 29750497
Sci Rep. 2020 Feb 3;10(1):1706
pubmed: 32015363
Sci Rep. 2021 Jan 14;11(1):1396
pubmed: 33446751
Chem Commun (Camb). 2005 Aug 7;(29):3664-6
pubmed: 16027904
J Am Chem Soc. 2020 Mar 18;142(11):4970-4974
pubmed: 32115942
Chem Rev. 2013 Jan 9;113(1):119-91
pubmed: 23256727

Auteurs

Jingxuan Ma (J)

Department of Biomedical and Chemical Engineering and Sciences, Florida Institute of Technology, 150 West University Blvd., Melbourne, FL 32901, United States.

Nishal M Egodawaththa (NM)

Department of Biomedical and Chemical Engineering and Sciences, Florida Institute of Technology, 150 West University Blvd., Melbourne, FL 32901, United States.

Charitha Guruge (C)

Department of Biomedical and Chemical Engineering and Sciences, Florida Institute of Technology, 150 West University Blvd., Melbourne, FL 32901, United States.

Oriana A Valladares Márquez (OAV)

Department of Biomedical and Chemical Engineering and Sciences, Florida Institute of Technology, 150 West University Blvd., Melbourne, FL 32901, United States.

Molly Likes (M)

Department of Biomedical and Chemical Engineering and Sciences, Florida Institute of Technology, 150 West University Blvd., Melbourne, FL 32901, United States.

Nasri Nesnas (N)

Department of Biomedical and Chemical Engineering and Sciences, Florida Institute of Technology, 150 West University Blvd., Melbourne, FL 32901, United States.

Classifications MeSH